A tailored course, built for your situation
Enterprise-Class AI in Pharmaceutical R&D Operations for Compliance Officers
Master implementation-grade AI governance for compliant, auditable drug development systems
The situation this course is for
AI-driven R&D pipelines are accelerating, but compliance frameworks often lag, relying on legacy processes unfit for dynamic, data-intensive systems. Officers face mounting pressure to validate models, ensure data integrity, and maintain audit readiness without clear methodologies or tools. This gap delays approvals, increases inspection risk, and limits strategic influence.
Who this is for
Compliance, quality assurance, and regulatory affairs professionals in pharmaceutical or biotech organizations who engage with AI-augmented R&D systems and need to ensure adherence to GxP, 21 CFR Part 11, and internal governance standards.
Who this is not for
This course is not for data scientists building models, entry-level compliance staff with no R&D exposure, or professionals outside regulated life sciences environments.
What you walk away with
- Apply structured governance frameworks to AI models in preclinical and clinical development
- Design audit-ready documentation and validation packages for AI components
- Evaluate data provenance, lineage, and integrity controls in AI-augmented workflows
- Align AI deployment with current regulatory expectations and inspection readiness
- Lead cross-functional coordination between data science, R&D, and compliance teams
The 12 modules (with all 144 chapters)
- Overview of AI applications in drug discovery
- Regulatory landscape for AI in life sciences
- Key compliance risks in AI-driven R&D
- Differences between traditional and AI-augmented workflows
- GxP applicability to AI systems
- Data lifecycle management principles
- Role of compliance in AI governance
- Case study: AI in preclinical target identification
- Defining 'validated' in the context of machine learning
- Regulatory body statements on AI use
- Internal policy development for AI oversight
- Establishing governance boundaries
- Model development lifecycle
- Defining model intent and use case
- Input data requirements and specifications
- Algorithm selection and documentation
- Training data provenance
- Validation dataset design
- Performance metric selection
- Bias and fairness assessment
- Validation protocols and reports
- Version control for models
- Retraining and update procedures
- Audit trail requirements
- ALCOA+ principles in AI contexts
- Data lineage mapping for AI workflows
- Source system validation
- Data transformation tracking
- Metadata requirements for AI inputs
- Handling unstructured data
- Data quality monitoring
- Anomaly detection in training data
- Data access and authorization logs
- Retention policies for AI datasets
- Third-party data governance
- Data reconciliation procedures
- Regulatory strategy for AI-enabled products
- Documentation required for submissions
- Common Technical Document integration
- FDA AI/ML guidance interpretation
- EMA perspectives on algorithmic transparency
- Inspection readiness for AI systems
- Preparing for regulatory questions
- Change control for AI updates
- Post-market monitoring plans
- Labeling considerations for AI features
- Interactions with regulatory bodies
- Global harmonization efforts
- Internal audit planning for AI
- Checklist development
- Evidence collection strategies
- Mock inspection exercises
- Regulatory inspection trends
- Responding to observations
- Corrective and preventive actions
- Audit trail review techniques
- Interview preparation for technical staff
- Document retention and retrieval
- Cross-functional audit coordination
- Lessons from recent AI-related inspections
- Change control process design
- Impact assessment for AI modifications
- Versioning strategies
- Rollback procedures
- Revalidation requirements
- Notification protocols
- Stakeholder communication plans
- Automated change detection
- Configuration management
- Deprecation and retirement
- Legacy system integration
- Continuous monitoring integration
- Risk identification in AI systems
- Hazard analysis techniques
- Failure mode and effects analysis
- Risk ranking and prioritization
- Mitigation strategy development
- Residual risk assessment
- Risk documentation standards
- Periodic risk review
- Integration with quality management systems
- Risk communication to leadership
- Third-party vendor risk
- Emerging risk trends
- Stakeholder identification
- Communication protocols
- Joint governance models
- Defining roles and responsibilities
- Conflict resolution strategies
- Technical translation for compliance
- Compliance translation for engineers
- Project governance structures
- Decision gate frameworks
- Escalation pathways
- Performance metrics alignment
- Shared documentation platforms
- Vendor selection criteria
- Contractual requirements
- Due diligence processes
- Audit rights and execution
- Data protection agreements
- Service level monitoring
- Subcontractor oversight
- Validation of vendor-provided models
- Knowledge transfer requirements
- Exit strategies
- Performance evaluation
- Ongoing monitoring frameworks
- Ethical AI principles
- Bias detection and mitigation
- Transparency requirements
- Explainability techniques
- Patient impact assessment
- Fairness in clinical applications
- Human oversight mechanisms
- Stakeholder engagement
- Ethics review boards
- Public trust considerations
- Regulatory expectations on ethics
- Documentation of ethical review
- Assessment of current state
- Gap analysis techniques
- Prioritization frameworks
- Pilot project design
- Resource planning
- Timeline development
- Stakeholder alignment
- Change management strategies
- Training program development
- Success metrics definition
- Scaling strategies
- Continuous improvement
- Emerging AI technologies
- Regulatory evolution tracking
- Adaptive licensing models
- Real-world evidence integration
- Digital twins in drug development
- Automated compliance monitoring
- AI for inspection prediction
- Strategic foresight methods
- Building compliance capability
- Thought leadership development
- Influencing organizational strategy
- Sustaining innovation in compliance
How this maps to your situation
- Implementing AI validation in early-phase R&D
- Preparing for FDA inspection of AI components
- Managing vendor-developed AI tools
- Scaling compliance frameworks across global teams
Before vs. after
What's included with your purchase
- 12 modules with 12 chapters each (144 chapters)
- Downloadable templates and worked examples for every module
- Hand-built implementation playbook delivered alongside course access
- 30-day money-back guarantee
Delivery and format
- Course and learning environment access provisioned within 24 hours of purchase
- Hand-built implementation playbook delivered alongside course access
Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.
Time investment: Approximately 60, 70 hours of focused learning, designed for completion over 8, 10 weeks with flexible pacing.
How this compares to the alternatives
Unlike generic AI ethics courses or technical machine learning programs, this course is specifically tailored to the implementation challenges faced by compliance officers in pharmaceutical R&D, combining regulatory depth, technical clarity, and actionable frameworks.
Frequently asked
Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.